• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开始对急性肾损伤的危重 III 期患者进行肾脏替代治疗。

Starting Kidney Replacement Therapy in Critically III Patients with Acute Kidney Injury.

机构信息

Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, 2-124E, Clinical Sciences Building, 8440-112 ST Northwest, Edmonton, Alberta T6G 2B7, Canada.

Division of Nephrology, St. Michael's Hospital and University of Toronto, and Li Ka Shing Knowledge Institute of St. Michael's Hospital, 30 Bond Street, Toronto, Ontario M5B 1W8, Canada.

出版信息

Crit Care Clin. 2021 Apr;37(2):409-432. doi: 10.1016/j.ccc.2020.11.005. Epub 2021 Feb 13.

DOI:10.1016/j.ccc.2020.11.005
PMID:33752864
Abstract

Kidney replacement therapy (KRT) is a core organ support in critical care settings. In patients suitable for escalation in support, who develop acute kidney injury (AKI) complications and urgent indications, there is consensus that KRT should be promptly initiated. In the absence of such urgent indications, the optimal timing has been less certain. Current clinical practice guidelines do not present strong recommendations for when to start KRT for patients with AKI in the absence of life-threatening and urgent indications. This article discusses how best to provide KRT to critically ill patients with severe AKI.

摘要

肾脏替代治疗(KRT)是重症监护环境中核心的器官支持手段。对于适合支持治疗升级且出现急性肾损伤(AKI)并发症和紧急指征的患者,共识认为应立即启动 KRT。在没有这些紧急指征的情况下,最佳时机则不太确定。目前的临床实践指南对于无生命威胁和紧急指征的 AKI 患者何时开始 KRT 没有提出强烈的推荐意见。本文讨论了如何为严重 AKI 的重症患者提供最佳的 KRT。

相似文献

1
Starting Kidney Replacement Therapy in Critically III Patients with Acute Kidney Injury.开始对急性肾损伤的危重 III 期患者进行肾脏替代治疗。
Crit Care Clin. 2021 Apr;37(2):409-432. doi: 10.1016/j.ccc.2020.11.005. Epub 2021 Feb 13.
2
Timing of kidney replacement therapy initiation in acute kidney injury.急性肾损伤中肾脏替代治疗的启动时机。
Curr Opin Nephrol Hypertens. 2021 May 1;30(3):332-338. doi: 10.1097/MNH.0000000000000707.
3
Strategies for the optimal timing to start renal replacement therapy in critically ill patients with acute kidney injury.危重症急性肾损伤患者开始肾脏替代治疗的最佳时机策略。
Kidney Int. 2017 May;91(5):1022-1032. doi: 10.1016/j.kint.2016.09.053. Epub 2017 Feb 17.
4
A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial.贝叶斯法重新分析标准与加速肾脏替代治疗启动时机急性肾损伤试验(STARRT-AKI)。
Crit Care. 2022 Aug 25;26(1):255. doi: 10.1186/s13054-022-04120-y.
5
Prognostic Impact of Early Versus Late Initiation of Renal Replacement Therapy Based on Early Warning Algorithm in Critical Care Patients With Acute Kidney Injury.基于早期预警算法的重症急性肾损伤患者早期与晚期开始肾脏替代治疗的预后影响。
Ther Apher Dial. 2020 Aug;24(4):445-452. doi: 10.1111/1744-9987.13449. Epub 2019 Nov 29.
6
Indications for and Timing of Initiation of KRT.开始肾脏替代治疗的适应证和时机。
Clin J Am Soc Nephrol. 2023 Jan 1;18(1):113-120. doi: 10.2215/CJN.05450522. Epub 2022 Sep 13.
7
The impact of higher protein dosing on outcomes in critically ill patients with acute kidney injury: a post hoc analysis of the EFFORT protein trial.高蛋白质剂量对急性肾损伤危重症患者结局的影响:EFFORT 蛋白质试验的事后分析。
Crit Care. 2023 Oct 18;27(1):399. doi: 10.1186/s13054-023-04663-8.
8
Indications and Timing of Continuous Renal Replacement Therapy Application.连续性肾脏替代治疗的应用指征及时机
Contrib Nephrol. 2018;194:25-37. doi: 10.1159/000485598. Epub 2018 Mar 29.
9
Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.早期与延迟启动肾脏替代治疗对急性肾损伤危重症患者死亡率的影响:ELAIN 随机临床试验。
JAMA. 2016;315(20):2190-9. doi: 10.1001/jama.2016.5828.
10
Acute Kidney Injury in the Critically Ill Patient: A Current Review of the Literature.危重症患者的急性肾损伤:文献综述
J Intensive Care Med. 2016 Jun;31(5):319-24. doi: 10.1177/0885066615575699. Epub 2015 Mar 9.

引用本文的文献

1
HMGB1 Is a Prognostic Factor for Mortality in Acute Kidney Injury Requiring Renal Replacement Therapy.高迁移率族蛋白 B1 是需要肾脏替代治疗的急性肾损伤患者死亡率的预后因素。
Blood Purif. 2023;52(7-8):660-667. doi: 10.1159/000530774. Epub 2023 Jun 19.
2
Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 1-2) on chronic kidney disease (stages 2-4): A multicenter randomized controlled clinical trial.川芎方联合还原型谷胱甘肽治疗慢性肾脏病(2-4期)急性肾损伤(1-2级):一项多中心随机对照临床试验。
Front Pharmacol. 2022 Oct 3;13:969107. doi: 10.3389/fphar.2022.969107. eCollection 2022.
3
Efficacy and Safety of Chuan Huang Fang Combining Reduced Glutathione in Treating Acute Kidney Injury (Grades 1-2) on Chronic Kidney Disease (Stages 2-4): Study Protocol for a Multicenter Randomized Controlled Clinical Trial.
川黄方联合还原型谷胱甘肽治疗慢性肾脏病(2-4期)急性肾损伤(1-2级)的疗效与安全性:一项多中心随机对照临床试验的研究方案
Evid Based Complement Alternat Med. 2022 Mar 15;2022:1099642. doi: 10.1155/2022/1099642. eCollection 2022.